Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: WESTAT, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-07-09 to 2023-11-30
Current total value of award: $507533
Description: EO14042 - THE PURPOSE OF THE DIETHYLSTILBESTROL (DES) EXPOSED COHORTS FOLLOW-UP STUDY, AS REQUIRED BY CONGRESSIONAL MANDATE UNDER THE DES RESEARCH AND EDUCATION AMENDMENTS OF 1992, IS TO CONTINUE TO MONITOR INDIVIDUALS PARTICIPATING IN STUDIES OF DES